ASX - By Stock
|
LTP |
Re:
Ann: SPONTAN achieves positive clinical study results
|
|
JackBNimble
|
117 |
33K |
6 |
15/06/24 |
15/06/24 |
ASX - By Stock
|
117
|
33K
|
6
|
|
ASX - By Stock
|
LTP |
Re:
Ann: SPONTAN achieves positive clinical study results
|
|
JackBNimble
|
117 |
33K |
9 |
12/06/24 |
12/06/24 |
ASX - By Stock
|
117
|
33K
|
9
|
|
ASX - By Stock
|
LTP |
Re:
Ann: SPONTAN achieves positive clinical study results
|
|
JackBNimble
|
117 |
33K |
9 |
11/06/24 |
11/06/24 |
ASX - By Stock
|
117
|
33K
|
9
|
|
ASX - By Stock
|
LTP |
Re:
IT WORKS!
|
|
JackBNimble
|
13 |
4.6K |
1 |
08/06/24 |
08/06/24 |
ASX - By Stock
|
13
|
4.6K
|
1
|
|
ASX - By Stock
|
LTP |
Re:
Ann: SPONTAN achieves positive clinical study results
|
|
JackBNimble
|
117 |
33K |
8 |
07/06/24 |
07/06/24 |
ASX - By Stock
|
117
|
33K
|
8
|
|
ASX - By Stock
|
LTP |
Re:
Ann: SPONTAN achieves positive clinical study results
|
|
JackBNimble
|
117 |
33K |
1 |
07/06/24 |
07/06/24 |
ASX - By Stock
|
117
|
33K
|
1
|
|
ASX - By Stock
|
LTP |
Re:
Ann: SPONTAN achieves positive clinical study results
|
|
JackBNimble
|
117 |
33K |
1 |
07/06/24 |
07/06/24 |
ASX - By Stock
|
117
|
33K
|
1
|
|
ASX - By Stock
|
LTP |
Re:
Ann: SPONTAN achieves positive clinical study results
|
|
JackBNimble
|
117 |
33K |
2 |
07/06/24 |
07/06/24 |
ASX - By Stock
|
117
|
33K
|
2
|
|
ASX - By Stock
|
LTP |
Re:
Ann: SPONTAN achieves positive clinical study results
|
|
JackBNimble
|
117 |
33K |
1 |
07/06/24 |
07/06/24 |
ASX - By Stock
|
117
|
33K
|
1
|
|
ASX - By Stock
|
LTP |
Re:
Ann: SPONTAN achieves positive clinical study results
|
|
JackBNimble
|
117 |
33K |
4 |
07/06/24 |
07/06/24 |
ASX - By Stock
|
117
|
33K
|
4
|
|
ASX - By Stock
|
LTP |
Re:
Ann: Reinstatement to quotation
|
|
JackBNimble
|
1 |
500 |
3 |
07/06/24 |
07/06/24 |
ASX - By Stock
|
1
|
500
|
3
|
|
ASX - By Stock
|
PAA |
Re:
Ann: OLE Study update reveals impressive Survival Data
|
|
JackBNimble
|
201 |
48K |
9 |
05/06/24 |
05/06/24 |
ASX - By Stock
|
201
|
48K
|
9
|
|
ASX - By Stock
|
LTP |
Re:
Ann: Trading Halt
|
|
JackBNimble
|
37 |
11K |
1 |
05/06/24 |
05/06/24 |
ASX - By Stock
|
37
|
11K
|
1
|
|
ASX - By Stock
|
LTP |
Re:
Ann: Trading Halt
|
|
JackBNimble
|
37 |
11K |
6 |
04/06/24 |
04/06/24 |
ASX - By Stock
|
37
|
11K
|
6
|
|
ASX - By Stock
|
LTP |
Re:
Ann: Trading Halt
|
|
JackBNimble
|
37 |
11K |
8 |
04/06/24 |
04/06/24 |
ASX - By Stock
|
37
|
11K
|
8
|
|
ASX - By Stock
|
LTP |
Re:
Ann: Trading Halt
|
|
JackBNimble
|
37 |
11K |
3 |
04/06/24 |
04/06/24 |
ASX - By Stock
|
37
|
11K
|
3
|
|
ASX - By Stock
|
GSS |
Re:
Ann: Genetic Signatures Announces $30 Million Capital Raising
|
|
JackBNimble
|
6 |
1.3K |
0 |
04/06/24 |
04/06/24 |
ASX - By Stock
|
6
|
1.3K
|
0
|
|
IPOs
|
Lithium |
Re:
Phoenix Water - PXW - Lithium - 100x
|
|
JackBNimble
|
1.9K |
1.3M |
1 |
03/06/24 |
03/06/24 |
IPOs
|
1.9K
|
1.3M
|
1
|
|
IPOs
|
Lithium |
Re:
Phoenix Water - PXW - Lithium - 100x
|
|
JackBNimble
|
1.9K |
1.3M |
2 |
03/06/24 |
03/06/24 |
IPOs
|
1.9K
|
1.3M
|
2
|
|
ASX - By Stock
|
PAA |
Re:
TOP 100 PAAO HOLDERS AS AT 31/05/24
|
|
JackBNimble
|
24 |
6.0K |
3 |
02/06/24 |
02/06/24 |
ASX - By Stock
|
24
|
6.0K
|
3
|
|
ASX - By Stock
|
PAA |
Re:
TOP 100 PAAO HOLDERS AS AT 31/05/24
|
|
JackBNimble
|
24 |
6.0K |
1 |
02/06/24 |
02/06/24 |
ASX - By Stock
|
24
|
6.0K
|
1
|
|
ASX - By Stock
|
PAA |
Re:
TOP 100 PAAO HOLDERS AS AT 31/05/24
|
|
JackBNimble
|
24 |
6.0K |
2 |
01/06/24 |
01/06/24 |
ASX - By Stock
|
24
|
6.0K
|
2
|
|
ASX - By Stock
|
PAA |
Re:
TOP 100 PAAO HOLDERS AS AT 31/05/24
|
|
JackBNimble
|
24 |
6.0K |
0 |
01/06/24 |
01/06/24 |
ASX - By Stock
|
24
|
6.0K
|
0
|
|
ASX - By Stock
|
PAA |
Re:
TOP 100 PAAO HOLDERS AS AT 31/05/24
|
|
JackBNimble
|
24 |
6.0K |
0 |
01/06/24 |
01/06/24 |
ASX - By Stock
|
24
|
6.0K
|
0
|
|
ASX - By Stock
|
PAA |
Re:
Ann: Executive team strengthened, appointment of MD/CEO & new CSO
|
|
JackBNimble
|
85 |
20K |
2 |
31/05/24 |
31/05/24 |
ASX - By Stock
|
85
|
20K
|
2
|
|
ASX - By Stock
|
PAA Biotech |
Re:
PAA, A New Dawn , FDA ODD Approval and Entering Phase II MND Trial
|
|
JackBNimble
|
560 |
133K |
14 |
31/05/24 |
31/05/24 |
ASX - By Stock
|
560
|
133K
|
14
|
|
ASX - By Stock
|
PAA Biotech |
Re:
PAA, A New Dawn , FDA ODD Approval and Entering Phase II MND Trial
|
|
JackBNimble
|
560 |
133K |
20 |
31/05/24 |
31/05/24 |
ASX - By Stock
|
560
|
133K
|
20
|
|
ASX - By Stock
|
PAA Biotech |
Re:
PAA, A New Dawn , FDA ODD Approval and Entering Phase II MND Trial
|
|
JackBNimble
|
560 |
133K |
7 |
31/05/24 |
31/05/24 |
ASX - By Stock
|
560
|
133K
|
7
|
|
ASX - By Stock
|
PAA Biotech |
Re:
PAA, A New Dawn , FDA ODD Approval and Entering Phase II MND Trial
|
|
JackBNimble
|
560 |
133K |
4 |
30/05/24 |
30/05/24 |
ASX - By Stock
|
560
|
133K
|
4
|
|
ASX - By Stock
|
PAA Biotech |
Re:
PAA, A New Dawn , FDA ODD Approval and Entering Phase II MND Trial
|
|
JackBNimble
|
560 |
133K |
9 |
30/05/24 |
30/05/24 |
ASX - By Stock
|
560
|
133K
|
9
|
|
IPOs
|
Lithium |
Re:
Phoenix Water - PXW - Lithium - 100x
|
|
JackBNimble
|
1.9K |
1.3M |
5 |
30/05/24 |
30/05/24 |
IPOs
|
1.9K
|
1.3M
|
5
|
|
ASX - By Stock
|
LTP |
Re:
Ann: Final Patients dosed in SPONTAN pivotal study
|
|
JackBNimble
|
109 |
31K |
2 |
30/05/24 |
30/05/24 |
ASX - By Stock
|
109
|
31K
|
2
|
|
ASX - By Stock
|
LTP |
Re:
Ann: Final Patients dosed in SPONTAN pivotal study
|
|
JackBNimble
|
109 |
31K |
0 |
28/05/24 |
28/05/24 |
ASX - By Stock
|
109
|
31K
|
0
|
|
ASX - By Stock
|
LTP |
Re:
Ann: Final Patients dosed in SPONTAN pivotal study
|
|
JackBNimble
|
109 |
31K |
1 |
28/05/24 |
28/05/24 |
ASX - By Stock
|
109
|
31K
|
1
|
|
ASX - By Stock
|
LTP |
Re:
Ann: Final Patients dosed in SPONTAN pivotal study
|
|
JackBNimble
|
109 |
31K |
1 |
28/05/24 |
28/05/24 |
ASX - By Stock
|
109
|
31K
|
1
|
|
IPOs
|
Lithium |
Re:
Phoenix Water - PXW - Lithium - 100x
|
|
JackBNimble
|
1.9K |
1.3M |
0 |
24/05/24 |
24/05/24 |
IPOs
|
1.9K
|
1.3M
|
0
|
|
ASX - By Stock
|
LTP |
Re:
Ann: Final Patients dosed in SPONTAN pivotal study
|
|
JackBNimble
|
109 |
31K |
1 |
24/05/24 |
24/05/24 |
ASX - By Stock
|
109
|
31K
|
1
|
|
ASX - By Stock
|
LTP |
Re:
Ann: Final Patients dosed in SPONTAN pivotal study
|
|
JackBNimble
|
109 |
31K |
0 |
24/05/24 |
24/05/24 |
ASX - By Stock
|
109
|
31K
|
0
|
|
ASX - By Stock
|
LTP |
Re:
Ann: Final Patients dosed in SPONTAN pivotal study
|
|
JackBNimble
|
109 |
31K |
0 |
22/05/24 |
22/05/24 |
ASX - By Stock
|
109
|
31K
|
0
|
|
ASX - By Stock
|
LTP |
Re:
Ann: Final Patients dosed in SPONTAN pivotal study
|
|
JackBNimble
|
109 |
31K |
0 |
22/05/24 |
22/05/24 |
ASX - By Stock
|
109
|
31K
|
0
|
|
ASX - By Stock
|
LTP |
Re:
Ann: Final Patients dosed in SPONTAN pivotal study
|
|
JackBNimble
|
109 |
31K |
0 |
22/05/24 |
22/05/24 |
ASX - By Stock
|
109
|
31K
|
0
|
|
ASX - By Stock
|
PAA Biotech |
Re:
PAA, A New Dawn , FDA ODD Approval and Entering Phase II MND Trial
|
|
JackBNimble
|
560 |
133K |
4 |
21/05/24 |
21/05/24 |
ASX - By Stock
|
560
|
133K
|
4
|
|
ASX - By Stock
|
PAA Biotech |
Re:
PAA, A New Dawn , FDA ODD Approval and Entering Phase II MND Trial
|
|
JackBNimble
|
560 |
133K |
8 |
21/05/24 |
21/05/24 |
ASX - By Stock
|
560
|
133K
|
8
|
|
ASX - By Stock
|
LTP |
Re:
Ann: Final Patients dosed in SPONTAN pivotal study
|
|
JackBNimble
|
109 |
31K |
2 |
21/05/24 |
21/05/24 |
ASX - By Stock
|
109
|
31K
|
2
|
|
ASX - By Stock
|
PAA Biotech |
Re:
PAA, A New Dawn , FDA ODD Approval and Entering Phase II MND Trial
|
|
JackBNimble
|
560 |
133K |
10 |
21/05/24 |
21/05/24 |
ASX - By Stock
|
560
|
133K
|
10
|
|
ASX - By Stock
|
PAA Biotech |
Re:
PAA, A New Dawn , FDA ODD Approval and Entering Phase II MND Trial
|
|
JackBNimble
|
560 |
133K |
17 |
21/05/24 |
21/05/24 |
ASX - By Stock
|
560
|
133K
|
17
|
|
ASX - By Stock
|
PAA Biotech |
Re:
PAA, A New Dawn , FDA ODD Approval and Entering Phase II MND Trial
|
|
JackBNimble
|
560 |
133K |
6 |
21/05/24 |
21/05/24 |
ASX - By Stock
|
560
|
133K
|
6
|
|
ASX - By Stock
|
LTP |
Re:
Ann: Final Patients dosed in SPONTAN pivotal study
|
|
JackBNimble
|
109 |
31K |
4 |
20/05/24 |
20/05/24 |
ASX - By Stock
|
109
|
31K
|
4
|
|
ASX - By Stock
|
LTP |
Re:
Ann: Final Patients dosed in SPONTAN pivotal study
|
|
JackBNimble
|
109 |
31K |
4 |
16/05/24 |
16/05/24 |
ASX - By Stock
|
109
|
31K
|
4
|
|
ASX - By Stock
|
LTP |
Re:
Ann: Final Patients dosed in SPONTAN pivotal study
|
|
JackBNimble
|
109 |
31K |
1 |
16/05/24 |
16/05/24 |
ASX - By Stock
|
109
|
31K
|
1
|
|